The pharmaceutical market in South Korea will rise from approximately $18.6 billion in 2016 to $20.4 billion in 2020, representing a compound annual growth rate (CAGR) of 2.4%. The Korean government is encouraging Research and Development (R&D) and sustaining growth initiatives in the pharmaceutical industry, such as the Korean Small Business Innovation Research program.
With 4,299 attendees from 57 countries attending the 2017 event, CPhI Korea provides the ideal platform to gain insights and do business with decision makers in the regional market. The exhibition is a key opportunity for you to accomplish months of business with these key decision makers over just a few days. With a high focus on the local market, the 2017 event saw participation of decision makers covering R&D, business development and sales and marketing.
What our exhibitors say
“The best part of CPhI Korea this year was that we could meet all the buyers from various countries including South East Asia, Africa, and CIS countries. We’ll definitely exhibit next year again."
Prakash P. Sapkal, Director of Zim Laboratories
“CPhI Korea was really helpful to establish marketing strategies in Korea through collecting Korean health ingredients market information from domestic exhibitors and buyers. Also, it was a good opportunity to meet many Korean companies who could be potential buyers.”
Edison Hsieh, Sales Manager of Contek Lifescience
“The Conference programme was very useful, featuring speakers from regulatory institutions of various regions. Also, it was great to have partnering opportunities through the 1:1 matchmaking programme. I think the programme will be very helpful for start-up companies especially."
Paul Cheon, Director of INIST ST
CPhI Korea is the Korean marketplace for pharmaceutical ingredients buyers, manufacturers and suppliers. The show represents all aspects of the ingredients market, including APIs, fine chemicals, biopharmaceuticals, excipients/formulation, intermediates, generic APIs, finished dosage and custom manufacturing.
ICSE Korea connects the global pharmaceutical community with Korean outsourcing solution providers, including clinical trials, contract research, custom manufacturing, biotechnology, IT, analytical services, packaging services and logistics.
P-MEC Korea brings together the global and Korean pharmaceutical machinery and equipment providers including analytical equipment, automation & robotics, batching systems/equipment, cleanroom equipment, health & safety products, instruments, laboratory equipment, machinery, packaging equipment & supplies, plant/facility equipment, process automation & controls, processing equipment, RFID, tableting and capsule fillers.
BioPh Korea focuses on biotechnology and related fields offering an ideal platform for biopharma companies, drug discovery organisations, pharma manufacturers and scientific research institutions to create new partnerships and discuss the latest biomedical and technological trends.
FDF Korea brings every aspect of the finished dosage supply chain together in one location, from Big Pharma and CMO, to out-licensing specialists, end product distributors, end user agents and home markets.
Hi Korea is a global meeting place for worldwide health ingredients manufacturers, traders, service providers, and other related professionals, including health/natural/functional/bio Ingredients, functional food additives, food technology/equipment, and contract manufacturing.
Exhibitors at CPhI Korea in 2017 were active in sectors including:
- Fine Chemicals & Intermediates
- Generic APIs
Exhibitors at ICSE, P-MEC and BioPh include:
- Contract services
- Technology and machinery
Want to book a stand?
By securing your exhibition space early you gain a number of significant benefits, including first choice of stand positions and visibility on our website as an exhibitor.
You can choose between the exhibition packages, depending on your requirements.
For more information on the packages available, please check the brochure.